DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

[Irreversible, non-selective monoamine oxidase inhibitors]

Author(s): Castberg I, Spigset O

Affiliation(s): Psykisk helsevern avdeling Ostmarka, St. Olavs hospital, Postboks 3008 Lade, 7441 Trondheim. ingrid.castberg@stolav.no

Publication date & source: 2009-04-16, Tidsskr Nor Laegeforen., 129(8):746-8.

Publication type: English Abstract

Irreversible, non-selective monoamine oxidase (MAO) inhibitors were among the first antidepressants. No drugs in this group are currently marketed in Norway, but many physicians will see patients using them, as they can be prescribed on a named patient basis after application to the Norwegian Medicines Agency. This article presents adverse effects, interactions and precautions related to the use of these drugs.

Page last updated: 2009-10-20

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017